Request Appointment
12605 E 16th AveAurora, CO 80045
Overview of Dr. Messersmith
Dr. Wells Messersmith is a medical oncologist in Aurora, CO and is affiliated with University of Colorado Hospital/University of Colorado Cancer Center. He received his medical degree from Harvard Medical School and has been in practice 17 years.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2001
Harvard Medical SchoolClass of 1998
Certifications & Licensure
CO State Medical License 2007 - 2025
MD State Medical License 2001 - 2015
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer Start of enrollment: 2019 Dec 09
- TR1801-ADC in Patients With Tumors That Express c-Met Start of enrollment: 2019 Aug 14
Publications & Presentations
PubMed
- 1 citationsRisk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer.Jacob B Leary, Junxiao Hu, Alexis Leal, S Lindsey Davis, Sunnie Kim
JCO Oncology Practice. 2025-03-01 - Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX.Thomas F Stoop, Toshitaka Sugawara, Atsushi Oba, Isabel M Feld, Stijn van Roessel
JAMA Oncology. 2025-03-01 - Nirogacestat-the pathway to approval of the first treatment for desmoid tumors, a rare disease.Shivaani Kummar, Nam Bui, Wells A Messersmith, Jeanne Whiting, Marlene Portnoy
Therapeutic Advances in Rare Disease. 2025-02-11
Press Mentions
Combination Slows Metastatic CRC Progression Better Than Single ImmunotherapyJanuary 27th, 2025- Triple Therapy in Metastatic CRC with BRAF Mutations: The New Standard of Care?January 26th, 2025
- A University of Colorado Leader Gets a Voice on National Cancer Research PolicyJanuary 13th, 2025
- Join now to see all
Grant Support
- The Johns Hopkins Translational Science Team and Consortium for ETCTN StudiesJOHNS HOPKINS UNIVERSITY2014–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
